K21R (p.Lys21Arg) variant of NFKBIA (NF-kappa-B inhibitor alpha)

K21R (p.Lys21Arg) in NFKBIA (NF-kappa-B inhibitor alpha) is a missense change. The available variant effect predictions contribute to a CATVariant prioritization score of 0.39 / 1. The record also includes population frequency data and structural context.

K21R (p.Lys21Arg) variant details